These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9454827)

  • 1. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells.
    Stauderman KA; Mahaffy LS; Akong M; Veliçelebi G; Chavez-Noriega LE; Crona JH; Johnson EC; Elliott KJ; Gillespie A; Reid RT; Adams P; Harpold MM; Corey-Naeve J
    J Pharmacol Exp Ther; 1998 Feb; 284(2):777-89. PubMed ID: 9454827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the recombinant human neuronal nicotinic acetylcholine receptors alpha3beta2 and alpha4beta2 stably expressed in HEK293 cells.
    Chavez-Noriega LE; Gillespie A; Stauderman KA; Crona JH; Claeps BO; Elliott KJ; Reid RT; Rao TS; Velicelebi G; Harpold MM; Johnson EC; Corey-Naeve J
    Neuropharmacology; 2000 Oct; 39(13):2543-60. PubMed ID: 11044726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
    Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
    Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ; Beck A; Luetje CW
    Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional properties of human nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of alpha3beta4 AChRs expressed in permanently transfected HEK cells.
    Nelson ME; Wang F; Kuryatov A; Choi CH; Gerzanich V; Lindstrom J
    J Gen Physiol; 2001 Nov; 118(5):563-82. PubMed ID: 11696612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
    Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
    Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine.
    Avalos M; Parker MJ; Maddox FN; Carroll FI; Luetje CW
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1246-52. PubMed ID: 12183686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the calcium dynamics of the human alpha4beta2, alpha3beta4 and alpha1beta1gammadelta nicotinic acetylcholine receptors.
    Michelmore S; Croskery K; Nozulak J; Hoyer D; Longato R; Weber A; Bouhelal R; Feuerbach D
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):235-45. PubMed ID: 12172706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand.
    Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Suto CM; Vernier JM
    Brain Res; 2003 Aug; 981(1-2):85-98. PubMed ID: 12885429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
    Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse beta-TC6 insulinoma cells: high expression of functional alpha3beta4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release.
    Ohtani M; Oka T; Badyuk M; Xiao Y; Kellar KJ; Daly JW
    Mol Pharmacol; 2006 Mar; 69(3):899-907. PubMed ID: 16332988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.
    Chavez-Noriega LE; Crona JH; Washburn MS; Urrutia A; Elliott KJ; Johnson EC
    J Pharmacol Exp Ther; 1997 Jan; 280(1):346-56. PubMed ID: 8996215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.
    Eaton JB; Peng JH; Schroeder KM; George AA; Fryer JD; Krishnan C; Buhlman L; Kuo YP; Steinlein O; Lukas RJ
    Mol Pharmacol; 2003 Dec; 64(6):1283-94. PubMed ID: 14645658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.
    Broad LM; Zwart R; Pearson KH; Lee M; Wallace L; McPhie GI; Emkey R; Hollinshead SP; Dell CP; Baker SR; Sher E
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1108-17. PubMed ID: 16738207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits.
    Wang F; Gerzanich V; Wells GB; Anand R; Peng X; Keyser K; Lindstrom J
    J Biol Chem; 1996 Jul; 271(30):17656-65. PubMed ID: 8663494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
    Xiao Y; Kellar KJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):98-107. PubMed ID: 15016836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
    Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.